Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Nucleic Acid-Peptide Drug Delivery Platform

Marina Biotech, Inc. MRNA, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application U.S. 11/955,207 with claims that cover a library of over 1x10(15) novel peptides.